MY202113A - Enterovirus 71 animal model - Google Patents

Enterovirus 71 animal model

Info

Publication number
MY202113A
MY202113A MYPI2017001107A MYPI2017001107A MY202113A MY 202113 A MY202113 A MY 202113A MY PI2017001107 A MYPI2017001107 A MY PI2017001107A MY PI2017001107 A MYPI2017001107 A MY PI2017001107A MY 202113 A MY202113 A MY 202113A
Authority
MY
Malaysia
Prior art keywords
enterovirus
animal model
relates
present
vpl
Prior art date
Application number
MYPI2017001107A
Inventor
Kaw Bing Chua
Original Assignee
Temasek Life Sciences Laboratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temasek Life Sciences Laboratory Ltd filed Critical Temasek Life Sciences Laboratory Ltd
Publication of MY202113A publication Critical patent/MY202113A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32371—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Environmental Sciences (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)

Abstract

The present invention relates to Enterovirus 71 (EV71), the development of an animal model and screening of candidate anti-EV71 compounds. More specifically, the present invention relates to the discovery that Enterovirus 71 (EV71) strains that have been adapted to infect rodent cell lines or cloned derived virus containing mutations in VPl can cause disease in immuno-competent rodents.
MYPI2017001107A 2015-01-28 2016-01-25 Enterovirus 71 animal model MY202113A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562108828P 2015-01-28 2015-01-28
US201562114880P 2015-02-11 2015-02-11
PCT/SG2016/050031 WO2016122403A1 (en) 2015-01-28 2016-01-25 Enterovirus 71 animal model

Publications (1)

Publication Number Publication Date
MY202113A true MY202113A (en) 2024-04-04

Family

ID=56543857

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017001107A MY202113A (en) 2015-01-28 2016-01-25 Enterovirus 71 animal model

Country Status (8)

Country Link
JP (1) JP6772155B2 (en)
KR (1) KR20170106473A (en)
CN (1) CN107849540B (en)
AU (1) AU2016212766B2 (en)
MY (1) MY202113A (en)
SG (1) SG11201706054QA (en)
TW (1) TWI764859B (en)
WO (1) WO2016122403A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112094822A (en) * 2019-06-02 2020-12-18 复旦大学 Infectious cDNA clone based on EV71 strain and application thereof
KR102243526B1 (en) * 2020-01-21 2021-04-22 (주)노터스생명과학 Transgenic animal for Nonclinical evaluation of Foot and Mouth Disease Vaccine and producing method thereof
WO2022140274A1 (en) * 2020-12-21 2022-06-30 Academia Sinica Novel enterovirus 71 mutations associated with disease severity
CN114304064A (en) * 2021-12-16 2022-04-12 首都医科大学 Method for establishing animal model with head deformity accompanied with nerve-dyskinesia
CN115211402A (en) * 2022-07-07 2022-10-21 中国医学科学院医学生物学研究所 Construction method and application of CV-B3 infected rodent model

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102220288B (en) * 2011-05-04 2013-07-17 中国科学院上海巴斯德研究所 Mouse-addapted enterovirus EV71 strain 573 and use thereof

Also Published As

Publication number Publication date
TWI764859B (en) 2022-05-21
AU2016212766A1 (en) 2017-09-07
CN107849540B (en) 2021-12-21
TW201702376A (en) 2017-01-16
AU2016212766B2 (en) 2022-03-24
SG11201706054QA (en) 2017-08-30
CN107849540A (en) 2018-03-27
JP6772155B2 (en) 2020-10-21
KR20170106473A (en) 2017-09-20
WO2016122403A1 (en) 2016-08-04
JP2018513671A (en) 2018-05-31

Similar Documents

Publication Publication Date Title
MY202113A (en) Enterovirus 71 animal model
MX2022001201A (en) Humanized sirpa-il15 knockin mice and methods of use thereof.
CY1123714T1 (en) NON-HUMAN ANIMALS EXPRESSING HUMANIZED CD3 COMPLEX
MD3445850T2 (en) Methods for providing single-stranded rna
PH12016502555A1 (en) Methods of preparing substituted nucleotide analogs
EA201691826A1 (en) METHOD OF USING GRAPHENE AND OTHER TWO-DIMENSIONAL MATERIALS IN VIVO AND IN VITRO
EA201792663A1 (en) METHODS OF SCREENING BACTERIA, ARCHEAN, ALGAE AND YEAST WITH THE USE OF CRISPR NUCLEIC ACIDS
EA201790630A1 (en) METHODS OF OBTAINING RIBOSIDS
GB2548059A (en) Induced hepatocytes and uses thereof
MX2021010060A (en) Production of viruses in avian eggs.
EA201791416A1 (en) POPULATION OF RPE CELLS AND METHODS TO OBTAIN THEM
WO2017048809A8 (en) Nk cells exhibiting an adaptive phenotype and methods for preparing and for using
BR112017025824A2 (en) vector mosquito control compositions, methods and products using them.
MX2019005102A (en) Synthetic chimeric poxviruses.
MX2020011586A (en) Synthetic chimeric vaccinia virus.
Culley et al. Characterization of the diversity of marine RNA viruses
MX2018005987A (en) Heterocyclic compounds for the treatment of disease.
MX2015016765A (en) Avian cells for improved virus production.
Keswani et al. Diversity, population and habitat used by spiders in bananaagro-ecosystem
DK3194602T3 (en) RELATIONSHIPS AND PROCEDURES TO ENHANCE VIRUS REVERSION TO HUMAN HEMATOPOIETIC CELLS
EA201591444A1 (en) MUTED ALLENOXIDE SYNTHASE 2 GENES (AOS2)
Полетаев et al. The potential of educational migration to professional education organizations in the context of the new migration policy
Kalla et al. ASSESSMENT OFTHE VIABILITY OF THE COCCOID FORM OF HELICOBACTER PYLORI IN MICE
王剑 FE 70-200mm F4 G OSS
FR3019063B1 (en) DILUTOR OF SAMPLES WITH PROPORTIONS DETERMINED BY WEIGHTING